Literature DB >> 17402732

Bifunctional binding of cisplatin to DNA: why does cisplatin form 1,2-intrastrand cross-links with ag but not with GA?

Yogita Mantri1, Stephen J Lippard, Mu-Hyun Baik.   

Abstract

The bifunctional binding of the anticancer drug cisplatin to two adjacent nucleobases in DNA is modeled using density functional theory. Previous experimental studies revealed that cisplatin binding to adjacent guanine and adenine is sensitive to nucleobase sequence. Whereas AG 1,2-intrastrand cross-links are commonly observed, the analogous GA adducts are not known. This study focuses on understanding this directional preference by constructing a full reaction profile using quantum chemical simulation methods. Monofunctional and bifunctional cisplatin adducts were generated, and the transition states that connect them were located for the dinucleotides d(pApG) and d(pGpA), assuming that initial platination takes place at the guanine site. Our computer simulations reveal a significant kinetic preference for formation of the AG over the GA adduct. The activation free energies of approximately 23 kcal/mol for AG and approximately 32 kcal/mol for GA suggest that bifunctional closure is approximately 6 orders of magnitude faster for AG than for GA. A strong hydrogen bond between one of the ammine ligands of cisplatin and the 5' phosphate group of the DNA backbone is responsible for the stabilization of the transition state that affords the AG adduct. This interaction is absent in the transition state that leads to the GA adduct because the right-handed helix of the DNA backbone places the phosphate out of reach for the ammine ligand. We found only an insignificant thermodynamic difference between AG and GA adducts and conclude that the preference of AG over GA binding is largely under kinetic control. The puckering of the deoxyribose ring plays an important role in determining the energetics of the bifunctional platination products. Whereas the 3'-nucleoside remains in the native C2'-endo/C3'-exo form of B-DNA, the deoxyribose of the 5'-nucleoside always adopts the C2'-exo/C3'-endo puckering in our simulations. A detailed analysis of the energies and structures of the bifunctional adducts revealed that the observed sugar puckering patterns are necessary for platinum to bind in a relaxed coordination geometry.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17402732      PMCID: PMC2495024          DOI: 10.1021/ja067631z

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  44 in total

1.  Generalized Gradient Approximation Made Simple.

Authors: 
Journal:  Phys Rev Lett       Date:  1996-10-28       Impact factor: 9.161

2.  Hydrolysis theory for cisplatin and its analogues based on density functional studies.

Authors:  Y Zhang; Z Guo; X Z You
Journal:  J Am Chem Soc       Date:  2001-09-26       Impact factor: 15.419

Review 3.  Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.

Authors:  D Lebwohl; R Canetta
Journal:  Eur J Cancer       Date:  1998-09       Impact factor: 9.162

4.  Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II).

Authors:  A Eastman
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

Review 5.  Cellular processing of platinum anticancer drugs.

Authors:  Dong Wang; Stephen J Lippard
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

Review 6.  Resistance to cisplatin.

Authors:  S Akiyama; Z S Chen; T Sumizawa; T Furukawa
Journal:  Anticancer Drug Des       Date:  1999-04

7.  On the competition of the purine bases, functionalities of peptide side chains, and protecting agents for the coordination sites of dicationic cisplatin derivatives.

Authors:  Dirk V Deubel
Journal:  J Am Chem Soc       Date:  2002-05-22       Impact factor: 15.419

Review 8.  Interactions of metal-metal-bonded antitumor active complexes with DNA fragments and DNA.

Authors:  Helen T Chifotides; Kim R Dunbar
Journal:  Acc Chem Res       Date:  2005-02       Impact factor: 22.384

9.  Cisplatin complexes with phosphatidylserine in membranes.

Authors:  G Speelmans; R W Staffhorst; K Versluis; J Reedijk; B de Kruijff
Journal:  Biochemistry       Date:  1997-08-26       Impact factor: 3.162

10.  DNA fragment conformations. A 1H-NMR conformational analysis of the d(G-G)-chelated platinum-oligonucleotide d(A-T-G-G)cisPt.

Authors:  J M Neumann; S Tran-Dinh; J P Girault; J C Chottard; T Huynh-Dinh; J Igolen
Journal:  Eur J Biochem       Date:  1984-06-15
View more
  22 in total

1.  DFT-based QSAR and QSPR models of several cis-platinum complexes: solvent effect.

Authors:  Pubalee Sarmah; Ramesh C Deka
Journal:  J Comput Aided Mol Des       Date:  2009-03-24       Impact factor: 3.686

2.  In vitro and in vivo antitumor activities and DNA binding mode of five coordinated cyclometalated organoplatinum(II) complexes containing biphosphine ligands.

Authors:  Michael Frezza; Q Ping Dou; Yan Xiao; Hamidreza Samouei; Mehdi Rashidi; Fayezeh Samari; Bahram Hemmateenejad
Journal:  J Med Chem       Date:  2011-08-24       Impact factor: 7.446

3.  Cisplatin bioconjugated enzymatic GNPs amplify the effect of cisplatin with acquiescence.

Authors:  Sana Iram; Manaal Zahera; Iram Wahid; Abu Baker; Mohammad Raish; Altaf Khan; Naushad Ali; Saheem Ahmad; Mohd Sajid Khan
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379

4.  Rapid cross-linking of an RNA internal loop by the anticancer drug cisplatin.

Authors:  Alethia A Hostetter; Erich G Chapman; Victoria J DeRose
Journal:  J Am Chem Soc       Date:  2009-07-08       Impact factor: 15.419

5.  Atomic level rendering of DNA-drug encounter.

Authors:  Maria F Lucas; Israel Cabeza de Vaca; Ryoji Takahashi; Jaime Rubio-Martínez; Víctor Guallar
Journal:  Biophys J       Date:  2014-01-21       Impact factor: 4.033

6.  A density functional reactivity theory (DFRT) based approach to understand the interaction of cisplatin analogues with protecting agents.

Authors:  Amrit Sarmah; Ram Kinkar Roy
Journal:  J Comput Aided Mol Des       Date:  2014-09-03       Impact factor: 3.686

7.  Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis.

Authors:  Suo-Fu Ye; Yong Yang; Lin Wu; Wei-Wei Ma; Hui-Hui Zeng
Journal:  J Zhejiang Univ Sci B       Date:  2017-05       Impact factor: 3.066

8.  Enzymatic processing of platinated RNAs.

Authors:  Erich G Chapman; Victoria J DeRose
Journal:  J Am Chem Soc       Date:  2010-02-17       Impact factor: 15.419

9.  G-quadruplex DNA-based asymmetric catalysis of michael addition: Effects of sonication, ligands, and co-solvents.

Authors:  Hua Zhao; Kai Shen
Journal:  Biotechnol Prog       Date:  2016-05-04

10.  QM/MM investigation into binding of square-planar platinum complexes to DNA fragments.

Authors:  Konstantinos Gkionis; James A Platts
Journal:  J Biol Inorg Chem       Date:  2009-07-09       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.